Refractory Focal Epilepsy: Clinical Trials

3 trials for Refractory Focal Epilepsy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 1 Early Phase 1, 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Early Phase 11Unknown 1
Not applicable1Completed 1
Phase 21Recruiting 1

Follow Refractory Focal Epilepsy: new trials by email Literature Review of Refractory Focal Epilepsy trials Research Report on Refractory Focal Epilepsy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
RAP-219 - Focal Epilepsy, Epilepsy
Phase 2RecruitingRapport Therapeutics Inc.302025-12-152026-01-23
Slow Oscillatory Transcranial Direct Current Stimulation for Refractory Focal Epilepsy
Slow-oscillatory transcranial direct current stimulation (so-tDCS) - Refractory Focal Epilepsy
Not applicableCompletedThe First Hospital of Hebei Medical University102024-01-132026-07-06
Induced Pluripotent Stem Cell Derived Exosomes Nasal Drops for the Treatment of Refractory Focal Epilepsy
iPSC-Exos - Refractory Focal Epilepsy
Early Phase 1UnknownPeking Union Medical College Hospital342023-06-052023-06-07

Narrower conditions

Epilepsies, Partial (3)  ·  Epilepsy (1)  ·  Seizures (1)

Broader conditions

Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Nervous System Diseases (3)  ·  Epilepsy (2)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Sponsors

Peking Union Medical College Hospital (1)  ·  Rapport Therapeutics Inc. (1)  ·  The First Hospital of Hebei Medical University (1)

Countries

China (2)  ·  United States (1)

Top investigators

Imran Quraishi, MD (1)  ·  Xiaohong Han (1)

Results publications

PMID 41613983